October 2023: A Significant Shift in FAA Policy In September and October 2023, the FAA introduced major changes that streamlined medical certification protocol and expanded eligibility for certain weight loss medications, including GLP-1 receptor agonists such as: Semaglutide (Wegovy) Liraglutide (Saxenda) Tirzepatide (Zepbound, Mounjaro) Rather than issuing blanket prohibitions, the FAA established specific pathways for certification (including a fast-track), observation periods, documentation requirements and ongoing monitoring
Will tirzepatide worsen my digestion after gallbladder surgery
However, a recently published case report demonstrated semaglutide-induced lupus erythematosus with multiple organ involvement [289]
Others maintain injections because they prefer the direct delivery and consistent results
This stuff gave me so much energy
However, all-cause infections were shown to be significantly increased after sitagliptin treatment, while did not reach statistical significance following vildagliptin therapy
